Author

M. Mendiburu-Elicabe

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Organism:chicken / avian· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Gutierrez-Uzquiza· 1 shared A. Lopez-Garcia· 1 shared A. M. Cuesta· 1 shared A. Porras· 1 shared A. Reyes-Palomares· 1 shared A. Vincelle-Nieto· 1 shared C. Baquero· 1 shared H. Hakonarson· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Gutierrez-Uzquiza

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel driver of metastasis in prostate cancer

M. Rodrigo-Faus, A. Vincelle-Nieto, N. Vidal, J. Puente, M. Saiz-Pardo, A. Lopez-Garcia, M. Mendiburu-Elicabe, N. Palao, C. Baquero, A. M. Cuesta, H.-Q. Qu, H. Hakonarson, M. Musteanu, A. Reyes-Palomares, A. Porras, , A. Gutierrez-Uzquiza

This study identifies PRMT7 as a novel driver of metastasis in prostate cancer through CRISPR/Cas9 screens and validates its role in promoting cell motility and tumor dissemination.

bioRxiv · Jul 20, 2023 · PreprintCancer Biology